Keyword Index
Browse for an article via relevant keywords across our entire electronic archive
Search results for: I
Results 101 - 110 of 403 shown below
immunochemotherapy
C M L van Herpen, R L H Jansen, W H J Kruit, K Hoekman, G Groenewegen, S Osanto and P H M De Mulder
Immunochemotherapy with interleukin-2, interferon-
and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II studydoi:10.1054/bjoc.1999.0997
immunoconjugate
S Tsunoda, I Ohizumi, J Matsui, K Koizumi, Y Wakai, H Makimoto, Y Tsutsumi, N Utoguchi, K Taniguchi, H Saito, N Harada, Y Ohsugi and T Mayumi
Specific binding of TES-23 antibody to tumour vascular endothelium in mice, rats and human cancer tissue: a novel drug carrier for cancer targeting therapy
doi:10.1038/sj.bjc.6690823
immunoconjugates
T L Cheng and S R Roffler
Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug
doi:10.1038/sj.bjc.6690221
Immunocytochemistry
G Pelosi, U Pastorino, F Pasini, P Maissoneuve, F Fraggetta, A lannucci, A Sonzogni, G De Manzoni, A Terzi, E Durante, E Bresaola, F Pezzella and G Viale
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer
doi:10.1038/sj.bjc.6600731
Abstract | Full article | PDF
-
D Vernimmen, M Gueders, S Pisvin, P Delvenne and R Winkler
Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers
doi:10.1038/sj.bjc.6601200
Abstract | Full article | PDF
-
S Garcia, J-P Dalès, J Jacquemier, E Charafe-Jauffret, D Birnbaum, L Andrac-Meyer, M-N Lavaut, C Allasia, S Carpentier-Meunier, P Bonnier and C Charpin-Taranger
c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays
doi:10.1038/sj.bjc.6603569
Abstract | Full article | PDF
-
G Mukherjee, B Muralidhar, U D Bafna, R A Laskey and N Coleman
MCM immunocytochemistry as a first line cervical screening test in developing countries: a prospective cohort study in a regional cancer centre in India
advance online publication, 2007-03-06 00:00:00.000;
doi:10.1038/sj.bjc.6603679
Abstract | Full article | PDF
-
M V Corrias, S Parodi, R Haupt, L Lacitignola, F Negri, A R Sementa, D Dau, F Scuderi, B Carlini, M Bianchi, F Casale, L Faulkner and A Garaventa
Detection of GD2-positive cells in bone marrow samples and survival of patients with localised neuroblastoma
advance online publication, 2008-01-08 00:00:00.000;
doi:10.1038/sj.bjc.6604179
Abstract | Full article | PDF
-
A Mezzelani, L Alasio, C Bartoli, M G Bonora, M A Pierotti, F Rilke and S Pilotti
c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates
doi:10.1038/sj.bjc.6690387
-
D Trerè, L Fiume, L Badiali De Giorgi, G Di Stefano, M Migaldi and M Derenzini
The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells
doi:10.1038/sj.bjc.6690708
-
G Pelosi, F Pasini, C Ottensmeier, F Pavanel, E Bresaola, A Bonetti, F Fraggetta, A Terzi, A Iannucci and G L Cetto
Immunocytochemical assessment of bone marrow aspirates for monitoring response to chemotherapy in small-cell lung cancer patients
doi:10.1038/sj.bjc.6690831
-
J Simony-Lafontaine, M Esslimani, E Bribes, S Gourgou, N Lequeux, R Lavail, J Grenier, A Kramar and P Casellas
Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors
doi:10.1054/bjoc.2000.1162
immunocytochemistry staining
L Perey, J Benhattar, R Peters, P Jaunin and S Leyvraz
High tumour contamination of leukaphereses in patients with small cell carcinoma of the lung: a comparison of immunocytochemistry and RT-PCR
doi:10.1054/bjoc.2001.2177
immunocytokine
C Heuser, M Ganser, A Hombach, H Brand, G Denton, F-G Hanisch and H Abken
An anti-MUC1-antibody–interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cells
doi:10.1038/sj.bjc.6601267
Abstract | Full article | PDF
immunocytology
K Beiske, S A Burchill, I Y Cheung, E Hiyama, R C Seeger, S L Cohn, A D J Pearson and K K Matthay
Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force
advance online publication, 2009-04-28 00:00:00.000;
doi:10.1038/sj.bjc.6605029
Abstract | Full article | PDF
-
H Nekarda, C Ge
, M Stark, U Fink, U Schenck and J R SiewertImmunocytochemically detected free peritoneal tumour cells (FPTC) are a strong prognostic factor in gastric carcinoma
doi:10.1038/sj.bjc.6690096
immunodeficiency
L Dal Maso, S Franceschi, A Lo Re and C La Vecchia
Comparison of the distribution of non-AIDS Kaposi's sarcoma and non-Hodgkin's lymphoma in Europe
doi:10.1038/sj.bjc.6690026
immunodetection
E Schultz-Thater, C Noppen, F Gudat, U Dürmüller, P Zajac, T Kocher, M Heberer and G C Spagnoli
NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens
doi:10.1054/bjoc.2000.1251
immunofluorescence
B H Joshi, P Leland, J Silber, R J Kreitman, I Pastan, M Berger and R K Puri
IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein
doi:10.1038/sj.bjc.6600034
Abstract | Full article | PDF
-
R Tedeschi, T Luostarinen, P De Paoli, R E Gislefoss, L Tenkanen, J Virtamo, P Koskela, G Hallmans, M Lehtinen and J Dillner
Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk
advance online publication, 2005-08-30 00:00:00.000;
doi:10.1038/sj.bjc.6602751
Abstract | Full article | PDF
